Genentech’s Perjeta Combination Therapy Effective for Aggressive Breast Cancer
Breast Cancer News, News
Newly released data from Genentech’s international phase 3 CLEOPATRA study demonstrates the efficacy of Perjeta treatment in patients with previously untreated HER2-positive metastatic breast cancer. Patient survival was extended by ... Read more